A detailed history of Kingsbury Capital Investment Advisors LLC transactions in Surface Oncology, Inc. stock. As of the latest transaction made, Kingsbury Capital Investment Advisors LLC holds 144,217 shares of SURF stock, worth $0. This represents 0.23% of its overall portfolio holdings.

Number of Shares
144,217
Previous 85,166 69.34%
Holding current value
$0
Previous $140,000 7.14%
% of portfolio
0.23%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$1.05 - $2.1 $62,003 - $124,007
59,051 Added 69.34%
144,217 $150,000
Q2 2022

Aug 09, 2022

BUY
$1.42 - $3.15 $76,364 - $169,400
53,778 Added 171.33%
85,166 $140,000
Q1 2022

May 16, 2022

BUY
$2.65 - $5.08 $83,178 - $159,451
31,388 New
31,388 $92,000

Others Institutions Holding SURF

# of Institutions
2
Shares Held
315K
Call Options Held
0
Put Options Held
0

About Surface Oncology, Inc.


  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Kingsbury Capital Investment Advisors LLC Portfolio

Follow Kingsbury Capital Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsbury Capital Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsbury Capital Investment Advisors LLC with notifications on news.